INNITIUS

INNITIUS develops medical hardware and software combining a novel torsional wave-based technology with AI to support diagnosis of conditions linked to changes in cervical tissue consistency. Current labor diagnostics often rely on subjective signs and imprecise tests — the company cites that 85% of women hospitalized for threatened preterm labor are false positives and 40% of spontaneous preterm labor cases go undetected at mid-trimester ultrasound. Its CerviSense device measures cervical softness via patented wave-based technology, and a proprietary AI algorithm combines this data with patient history to deliver an actionable birth-timing risk assessment.